Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer.

Ferroni P, Roselli M, Buonomo OC, Spila A, Portarena I, Laudisi A, Valente MG, Pirillo SP, Fortunato L, Costarelli L, Cavaliere F, Guadagni F.

Anticancer Res. 2018 Aug;38(8):4705-4712. doi: 10.21873/anticanres.12777.

PMID:
30061239
2.

Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?

Costarelli L, Campagna D, Ascarelli A, Cavaliere F, Colavito MH, Ponzani T, Broglia L, La Pinta M, Manna E, Fortunato L.

Breast Cancer (Dove Med Press). 2017 Dec 8;9:581-586. doi: 10.2147/BCTT.S145570. eCollection 2017.

3.

Impact of agrochemicals on non-target species: Calathus fuscipes Goeze 1777 (Coleoptera: Carabidae) as model.

Giglio A, Cavaliere F, Giulianini PG, Mazzei A, Talarico F, Vommaro ML, Brandmayr P.

Ecotoxicol Environ Saf. 2017 Aug;142:522-529. doi: 10.1016/j.ecoenv.2017.04.056. Epub 2017 May 4.

PMID:
28478378
4.

Oxidant stress as a major determinant of platelet activation in invasive breast cancer.

Ferroni P, Santilli F, Cavaliere F, Simeone P, Costarelli L, Liani R, Tripaldi R, Riondino S, Roselli M, Davi G, Guadagni F.

Int J Cancer. 2017 Feb 1;140(3):696-704. doi: 10.1002/ijc.30488. Epub 2016 Nov 7.

5.

Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.

Hamilton DH, Roselli M, Ferroni P, Costarelli L, Cavaliere F, Taffuri M, Palena C, Guadagni F.

Endocr Relat Cancer. 2016 Oct;23(10):783-796. doi: 10.1530/ERC-16-0037.

6.

Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.

Roselli M, Ferroni P, Riondino S, Mariotti S, Portarena I, Alessandroni J, Ialongo C, Massoud R, Costarelli L, Cavaliere F, Bernardini S, Guadagni F.

Am J Cancer Res. 2016 Jun 1;6(6):1450-7. eCollection 2016.

7.

Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.

Ferroni P, Riondino S, Laudisi A, Portarena I, Formica V, Alessandroni J, D'Alessandro R, Orlandi A, Costarelli L, Cavaliere F, Guadagni F, Roselli M.

Oncologist. 2016 Sep;21(9):1041-9. doi: 10.1634/theoncologist.2015-0462. Epub 2016 Jul 7.

8.

Once Daily Accelerated Partial Breast Irradiation: Preliminary Results with Helical Tomotherapy®.

DE Paula U, D'Angelillo RM, Barbara R, Caruso C, Gomellini S, Caccavari A, Costarelli L, Scavina P, Mauri M, Santini E, Antonaci A, Cavaliere F, LA Pinta M, Loreti A, Fortunato L.

Anticancer Res. 2016 Jun;36(6):3035-9.

PMID:
27272823
9.

Insulin resistance as a predictor of venous thromboembolism in breast cancer.

Ferroni P, Roselli M, Riondino S, Cavaliere F, Guadagni F.

Endocr Relat Cancer. 2016 Jun;23(6):L25-8. doi: 10.1530/ERC-16-0187. Epub 2016 May 16. No abstract available.

PMID:
27185869
10.

Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy.

Santoro S, Loreti A, Cavaliere F, Costarelli L, La Pinta M, Manna E, Mauri M, Scavina P, Santini E, De Paula U, Toto V, Fortunato L.

Breast. 2015 Oct;24(5):661-6. doi: 10.1016/j.breast.2015.08.001. Epub 2015 Sep 3.

PMID:
26343944
11.

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

Palena C, Roselli M, Litzinger MT, Ferroni P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI, Hamilton DH, Jochems C, Tsang KY, Cheng Q, Lyerly HK, Schlom J, Guadagni F.

J Natl Cancer Inst. 2014 May 9;106(5). pii: dju054. doi: 10.1093/jnci/dju054.

12.

Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome.

Ferroni P, Roselli M, Portarena I, Formica V, Riondino S, LA Farina F, Costarelli L, Melino A, Massimiani G, Cavaliere F, Palmirotta R, Guadagni F.

Anticancer Res. 2014 Mar;34(3):1153-61.

PMID:
24596353
13.

Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.

Roselli M, Ferroni P, Riondino S, Mariotti S, Laudisi A, Vergati M, Cavaliere F, Palmirotta R, Guadagni F.

Int J Cancer. 2013 Sep 1;133(5):1253-8. doi: 10.1002/ijc.28104. Epub 2013 Mar 16.

14.

A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes.

Palmirotta R, Ludovici G, De Marchis ML, Leone B, Formica V, Ettorre GM, Cavaliere F, Della-Morte D, Ferroni P, Roselli M, Guadagni F.

In Vivo. 2012 Jul-Aug;26(4):537-47.

PMID:
22773565
15.

Association between Birt Hogg Dube syndrome and cancer predisposition.

Palmirotta R, Savonarola A, Ludovici G, Donati P, Cavaliere F, DE Marchis ML, Ferroni P, Guadagni F.

Anticancer Res. 2010 Mar;30(3):751-7. Review.

PMID:
20392993
16.

Peritoneal carcinomatosis from ovarian epithelial primary: combined aggressive treatment.

Cavaliere F, Giannarelli D, Valle M, Federici O, Liotta G, Perri P, Di Filippo F, Garofalo A, Ialongo P.

In Vivo. 2009 May-Jun;23(3):441-6.

17.

Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.

Di Filippo F, Rossi CR, Santinami M, Cavaliere F, Garinei R, Anzà M, Perri P, Botti C, Di Angelo P, Pasqualoni R, Di Filippo S.

In Vivo. 2006 Nov-Dec;20(6A):739-42.

18.

Liposomal doxorubicin with and without TNFalpha in the perfusional treatment of advanced soft tissue limb sarcoma: preliminary results.

Di Filippo F, Anzà M, Garinei R, Cavaliere F, Perri P, Botti C, Di Angelo P, Di Filippo S, Maini CL, Pasqualoni R, Di Segni S, Colantonio S, Bruno P, Piarulli L, Principi F.

In Vivo. 2006 Nov-Dec;20(6A):735-8.

19.

Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.

Rossi CR, Deraco M, De Simone M, Mocellin S, Pilati P, Foletto M, Cavaliere F, Kusamura S, Gronchi A, Lise M.

Cancer. 2004 May 1;100(9):1943-50.

20.

Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.

Rossi CR, Foletto M, Mocellin S, Pilati P, De SM, Deraco M, Cavaliere F, Palatini P, Guasti F, Scalerta R, Lise M.

Cancer. 2002 Jan 15;94(2):492-9.

Supplemental Content

Loading ...
Support Center